 |
| Immunology Market |
Immunology deals with the scientific study of the immune system, its functions, structure, components, and its relationship with other body systems. The immune system protects the body against infectious agents and other invaders. Some key products in immunology market include monoclonal antibodies, inflammatory & anti-infective cytokines, immunostimulatory antibodies, and recombinant cytokines & growth factors. Monoclonal antibodies have wide applications in treatment of various conditions such as cancer, cardiovascular & metabolic diseases, and inflammatory disorders.
The global
Immunology Market is estimated to be valued at US$ 107133.84 Mn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key Trends:
Increased applications of monoclonal antibodies is one of the key trends
driving growth of the immunology market. Monoclonal antibodies have
revolutionized the treatment of various diseases. They bind to specific
antigens on invaders or diseased cells and trigger immune responses against
those targets. For instance, monoclonal antibodies like Rituximab and
Adalimumab are being widely used for treatment of cancer and autoimmune
diseases such as rheumatoid arthritis. Advancements in monoclonal antibody drug
development coupled with major drug approvals by regulatory agencies are
increasing applications of monoclonal antibodies across many therapeutic areas.
This is fueling revenue growth of immunology market over the forecast period.
Segment Analysis
The global immunology market is dominated by the therapeutic antibody segment.
Monoclonal antibodies (mAbs) have revolutionized medicine and transformed the
treatment of various diseases like cancer, autoimmune disorders, inflammatory
diseases. Therapeutic antibodies accounted for over 60% of the immunology
market share in 2023, given the high specificity and affinity of mAbs for their
specific target.
Key Takeaways
The global Immunology
Market Share is expected to witness high growth over the forecast
period of 2023 to 2030. Rapid advances in immunotherapy and growing target
disease incidence will drive significant gains. The global Immunology Market is
estimated to be valued at US$ 107133.84 Mn in 2023 and is expected to exhibit a
CAGR of 17% over the forecast period 2023 to 2030.
Regional analysis:
North America currently dominates the immunology market,
capturing over 40% share in 2024. The United States accounts for the bulk of
the region's demand given the large healthcare expenditure and rapid uptake of
novel immunotherapies. Asia Pacific is projected to witness the fastest growth
during the forecast period owing to rising healthcare spending, growing
middle-class population and increasing focus on quality care in China, India,
and South Korea.
Key players:
Key players operating in the immunology market are Production I.G,
Inc., Studio Ghibli, Inc., Pierrot Co., Ltd., Sunrise Inc., Toei Animation Co.,
Ltd., BONES INC, Kyoto Animation Co.,Ltd., MADHOUSE Inc., Manglobe Inc., and
PAWORKS Co., Ltd. Production I.G, Inc. and Studio Ghibli, Inc. collectively
accounted for over 25% of the global immunology market in 2024. Production I.G
is a leading player known for its expertise in TV series and movies development.
Whereas Studio Ghibli is dominant for its movie portfolio. Strong R&D and
strategic acquisitions have enabled these players to bolster their product
pipelines and market share.
For more insights, read- https://www.ukwebwire.com/immunology-market-value-demand-analysis-and-forecast/
For more details on the
report, Read- https://www.newsstatix.com/luxury-travel-market-trends-size-and-share-analysis/
0 Comments